Targetted Delivery Of

We have collected information about Targetted Delivery Of for you. Follow the links to find out details on Targetted Delivery Of.


Progress and challenges towards targeted delivery of ...

    https://www.nature.com/articles/s41467-018-03705-y
    Apr 12, 2018 · Introduction Approaches for targeted delivery of therapeutics in cancer typically involves systemic administration of therapeutics packaged in nanocarriers (NCs) or localized delivery of...Author: Daniel Rosenblum, Nitin Joshi, Nitin Joshi, Wei Tao, Jeffrey M. Karp, Jeffrey M. Karp, Dan Peer

Targeted delivery of a PD-1-blocking scFv by CAR-T cells ...

    https://www.ncbi.nlm.nih.gov/pubmed/30102295
    1. Nat Biotechnol. 2018 Oct;36(9):847-856. doi: 10.1038/nbt.4195. Epub 2018 Aug 13. Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo.Author: Sarwish Rafiq, Oladapo O Yeku, Hollie J Jackson, Terence J Purdon, Dayenne G van Leeuwen, Dylan J Dr...

Progress and challenges towards targeted delivery of ...

    https://www.ncbi.nlm.nih.gov/pubmed/29650952
    Apr 12, 2018 · Targeted delivery approaches for cancer therapeutics have shown a steep rise over the past few decades. However, compared to the plethora of successful pre-clinical studies, only 15 passively targeted nanocarriers (NCs) have been approved for clinical use and none of the actively targeted NCs have advanced past clinical trials.Author: Daniel Rosenblum, Nitin Joshi, Nitin Joshi, Wei Tao, Jeffrey M. Karp, Jeffrey M. Karp, Dan Peer

Inflammation-Targeted Delivery of Celastrol via Neutrophil ...

    https://pubs.acs.org/doi/abs/10.1021/acs.molpharmaceut.8b01342
    Together, these results suggest that NNPs/CLT represent a highly promising delivery vehicle for the targeted therapy of AP. Inflammation-Targeted Delivery of Celastrol via Neutrophil Membrane-Coated Nanoparticles in the Management of Acute Pancreatitis Molecular PharmaceuticsAuthor: Xu Zhou, Xi Cao, He Tu, Zhi-Rong Zhang, Li Deng

Targeted delivery of a PD-1-blocking scFv by CAR-T cells ...

    https://www.nature.com/articles/nbt.4195
    Oct 01, 2018 · Anti-PD-1 secreted by CAR-T cells remains localized to the tumor and improves therapeutic outcome in mice. The efficacy of chimeric antigen receptor (CAR) T cell therapy against poorly responding ...Author: Sarwish Rafiq, Oladapo O Yeku, Hollie J Jackson, Terence J Purdon, Dayenne G van Leeuwen, Dylan J Dr...

Searching for Targetted Delivery Of?

You can just click the links above. The data is collected for you.

Related Delivery Info